Search research articles
Contact Us
Filters
Showing results (241-250 of 673) with videos related to
Page
of 68
Sort By:
Immunopharmacology and Immunotoxicology
|
January 1, 1992
Effect of stilbene-type anion channel blockers on the immune response during experimental allergic neuritis (EAN)
E Mix, J Correale, T Olsson, et al.
Scandinavian Journal of Immunology
|
March 13, 1999
Phenotypic and functional properties of dendritic cells isolated from human peripheral blood in comparison with mononuclear cells and T cells
Y M Huang, B G Xiao, I Westerlund, et al.
Clinical and Experimental Immunology
|
April 1, 1994
Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection
V Navikas, J Link, B Wahren, et al.
Acta Neurologica Scandinavica
|
September 1, 1994
Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
U Fiszer, E Mix, S Fredrikson, et al.
The New England Journal of Medicine
|
June 28, 1990
Intrasynovial production of oligoclonal specific antibodies in Lyme arthritis
M H Cruz, K Hansen, K L Faarvang, et al.
Blut
|
July 1, 1985
Therapy for acute myeloid leukemia in 119 adults: a comparison of two treatment protocols
H Link, H M Frauer, P Ostendorf, et al.
Infection and Immunity
|
August 1, 1997
Potential role of autoantibodies in the regulation of cytokine responses during bacterial infections
M Bakhiet, A Diab, Mahamustafa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 23, 2000
Persistence of tropical ataxic neuropathy in a Nigerian community
O S Oluwole, A O Onabolu, H Link, et al.
Journal of Neuroimmunology
|
December 8, 2000
Monocytes in multiple sclerosis: phenotype and cytokine profile
M Kouwenhoven, N Teleshova, V Ozenci, et al.
Klinische Wochenschrift
|
April 1, 1983
[Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures]
H Link, H M Frauer, K Wilms, et al.
Page
of 68
Search research articles
Search
Showing results (241-250 of 673) with videos related to
Sort By:
Page
of 68
Immunopharmacology and Immunotoxicology
|
January 1, 1992
Effect of stilbene-type anion channel blockers on the immune response during experimental allergic neuritis (EAN)
E Mix, J Correale, T Olsson, et al.
Scandinavian Journal of Immunology
|
March 13, 1999
Phenotypic and functional properties of dendritic cells isolated from human peripheral blood in comparison with mononuclear cells and T cells
Y M Huang, B G Xiao, I Westerlund, et al.
Clinical and Experimental Immunology
|
April 1, 1994
Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection
V Navikas, J Link, B Wahren, et al.
Acta Neurologica Scandinavica
|
September 1, 1994
Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
U Fiszer, E Mix, S Fredrikson, et al.
The New England Journal of Medicine
|
June 28, 1990
Intrasynovial production of oligoclonal specific antibodies in Lyme arthritis
M H Cruz, K Hansen, K L Faarvang, et al.
Blut
|
July 1, 1985
Therapy for acute myeloid leukemia in 119 adults: a comparison of two treatment protocols
H Link, H M Frauer, P Ostendorf, et al.
Infection and Immunity
|
August 1, 1997
Potential role of autoantibodies in the regulation of cytokine responses during bacterial infections
M Bakhiet, A Diab, Mahamustafa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 23, 2000
Persistence of tropical ataxic neuropathy in a Nigerian community
O S Oluwole, A O Onabolu, H Link, et al.
Journal of Neuroimmunology
|
December 8, 2000
Monocytes in multiple sclerosis: phenotype and cytokine profile
M Kouwenhoven, N Teleshova, V Ozenci, et al.
Klinische Wochenschrift
|
April 1, 1983
[Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures]
H Link, H M Frauer, K Wilms, et al.
Page
of 68